Bioactive Composite Versus Resin-Modified Glass Ionomer Liners: 2-Year Clinical Trial

Bioactive Ionic Resin Composite Versus Resin-Modified Glass Ionomer Cavity Liners: 2-Year Randomized Clinical Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05470959

Acronym

BIRCRMGILYCT

Enrollment

Registered

2022-07-22

Start date

2019-10-10

Completion date

2021-12-20

Last updated

2022-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries

Brief summary

compare 2-year clinical performance of recent bioactive ionic resin composite to resin-modified glass ionomer liner in indirect dental pulp treatment.

Detailed description

patients were enrolled in the clinical trial. Each patient had two deep carious lesions, one on each side of the mouth. After selective caries removal, cavities were lined with bioactive ionic resin composite (Activa Bioactive Liner/Base) or resin-modified glass ionomer liner (Riva Light Cure RMGI). All cavities were then restored with nanofilled resin composite (Filtek Z350xt). All materials were placed according to the manufacturers' instructions. Clinical evaluation was accomplished using World Dental Federation (FDI) criteria at baseline and after 6 months, one year, one and half years, and two years.

Interventions

OTHERACTIVA bioactive

bioactive ionic resin composite

OTHERRiva LC

resin-modified glass ionomer

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* presence of two deep carious lesions, one on each side of the mouth (ICDAS 5 or 6) * vital teeth * no sensitivity to teeth percussion * no spontaneous pain * no radiolucency in the periapical or furcation area of teeth * complete and normal occlusion * good oral hygiene

Exclusion criteria

* poor oral hygiene * severe or chronic periodontal problems * periapical lesions * heavy bruxism * non-vital teeth * visibly cracked teeth * spontaneous dental pain * sensitivity to teeth percussion

Design outcomes

Primary

Measure	Time frame	Description
assess clinical performance of bioactive ionic resin composite and resin-modified glass ionomer liner by using FDI clinical criteria	2-years	comparison of 2-year clinical performance of recent bioactive ionic resin composite( ACTIVA bioactive) to resin-modified glass ionomer liner ( Riva LC) in indirect dental pulp treatment using FDI world dental federation clinical criteria.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026